Stock & Company Details
Invivyd Inc $IVVD
Price:
N/A
N/A
295M
$206M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.96
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IVVD technical indicators
Latest Invivyd Inc (IVVD) indicator readings as of 2026-10-09.
IVVD's 14-day RSI is 40.4, in neutral territory. At $0.72 it is trading 44.9% below its 200-day moving average of $1.31, and below its 50-day average of $0.81. Price sits near the lower Bollinger Band ($0.67 to $1.01). ADX reads 15.3, indicating a range-bound market rather than a trend.
Overview
Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with third-party contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
Finance Bot
Ask your questions
Start by typing a question below.
